← FDA Drug Approvals (Drugs@FDA)
DIFLUPREDNATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: UPSHER SMITH LABS · Approved 2025-02-11
Drug application
- FDA Application #
ANDA218191- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DIFLUPREDNATE
- Generic name
- DIFLUPREDNATE
- Active ingredients
- DIFLUPREDNATE
- Dosage form
- EMULSION
- Route
- OPHTHALMIC
- Marketing status
- Prescription
- Sponsor
- UPSHER SMITH LABS
- Manufacturer
- Upsher-Smith Laboratories, LLC
- First approval
- 2025-02-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown